Wolfe Research started coverage on shares of Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $42.00 price target on the stock. Wolfe Research‘s price target would indicate a potential upside of 22.08% from the company’s previous close.
Several other equities analysts have also recently weighed in on the stock. Barclays raised their price target on shares of Keurig Dr Pepper from $38.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, November 5th. Citigroup increased their price objective on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, November 4th. BNP Paribas Exane increased their price objective on Keurig Dr Pepper from $28.00 to $29.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Deutsche Bank raised their target price on Keurig Dr Pepper from $30.00 to $32.00 and gave the company a “hold” rating in a report on Friday, August 7th. Finally, Morgan Stanley lifted their target price on Keurig Dr Pepper from $38.00 to $40.00 and gave the company an “overweight” rating in a research report on Wednesday, November 4th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $37.56.
Check Out Our Latest Stock Report on KDP
Keurig Dr Pepper Stock Performance
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. The firm had revenue of $7.34 billion during the quarter, compared to analysts’ expectations of $7.33 billion. Keurig Dr Pepper had a net margin of 7.12% and a return on equity of 11.27%. The business’s revenue was up 70.6% on a year-over-year basis. During the same period last year, the company earned $0.54 earnings per share. On average, analysts expect that Keurig Dr Pepper will post 2.31 EPS for the current fiscal year.
Insider Buying and Selling
In other Keurig Dr Pepper news, Director Aaron Alt purchased 7,862 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The shares were acquired at an average cost of $31.83 per share, for a total transaction of $250,247.46. Following the completion of the acquisition, the director owned 7,862 shares of the company’s stock, valued at $250,247.46. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the business’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $32.55, for a total value of $390,600.00. Following the completion of the transaction, the insider directly owned 84,171 shares in the company, valued at approximately $2,739,766.05. This represents a 12.48% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.34% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Keurig Dr Pepper
A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new position in shares of Keurig Dr Pepper during the 2nd quarter valued at $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of Keurig Dr Pepper during the 2nd quarter worth $767,105,000. Bank of America Corp DE bought a new position in shares of Keurig Dr Pepper during the 2nd quarter worth $281,503,000. Legal & General Group Plc purchased a new stake in Keurig Dr Pepper in the 2nd quarter worth about $269,336,000. Finally, Boston Partners increased its holdings in Keurig Dr Pepper by 182.9% in the 3rd quarter. Boston Partners now owns 8,340,288 shares of the company’s stock worth $253,079,000 after acquiring an additional 5,391,668 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors.
About Keurig Dr Pepper
Keurig Dr Pepper Inc. (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods. The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Recommended Stories
- Five stocks we like better than Keurig Dr Pepper
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
